Accolade, Inc. (NASDAQ:ACCD) recently disclosed stock transactions involving its Chief Financial Officer, Stephen H. Barnes. According to a recent SEC filing, Barnes sold 458 shares of Accolade common stock on November 4, 2024, at a price of $3.149 per share, totaling $1,442. This sale was conducted to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) and was not a discretionary transaction by Barnes.
Additionally, on November 1, 2024, Barnes acquired 1,569 shares of Accolade common stock through the conversion of RSUs. This transaction did not involve any cash exchange, as each RSU converted directly into one share of common stock. Following these transactions, Barnes holds 204,452 shares of Accolade common stock directly.
In other recent news, Accolade Inc (NASDAQ:ACCD). continues to make headlines with its financial performance. The healthcare solutions provider has reported strong second-quarter results for 2025, surpassing revenue expectations with a total of $106.4 million and exceeding its adjusted EBITDA guidance. The company also confirmed its fiscal year 2025 revenue guidance between $460 million to $475 million and projected a positive adjusted EBITDA of $15 million to $20 million.
However, Wells Fargo (NYSE:WFC) has revised Accolade's price target downwards to $6.00 due to concerns over the timing of deal closures and their impact on the company's anticipated growth. Similarly, Stephens, Canaccord Genuity, Truist Securities, and BofA Securities have also adjusted their price targets for Accolade, maintaining Buy ratings despite the reductions.
Despite these revisions, analysts from these firms express confidence in Accolade's ability to meet performance guarantees and secure new business. The company's management has also shown optimism about a strong pipeline with diversification across employers, health plans, and government segments. However, slower revenue growth is anticipated in fiscal year 2026 due to staggered launches. These are recent developments for the company, reflecting the dynamic nature of its financial performance.
InvestingPro Insights
While Accolade's CFO Stephen H. Barnes recently engaged in stock transactions related to RSU vesting, it's important to consider the broader financial context of the company. According to InvestingPro data, Accolade's market capitalization stands at $259.33 million, with a revenue of $441.03 million for the last twelve months as of Q2 2025. The company has shown revenue growth of 16.04% over the same period, indicating some positive momentum in its business operations.
However, InvestingPro Tips reveal that Accolade's stock price movements have been quite volatile, and the stock has fared poorly over the last month, with a 1-month price total return of -16.0%. This volatility aligns with the recent insider transaction and may be of interest to investors monitoring the company's stock performance.
Another relevant InvestingPro Tip highlights that Accolade operates with a moderate level of debt, which could be a factor in the company's financial strategy and future growth plans. This information provides additional context to the insider transactions and the company's overall financial position.
For investors seeking a more comprehensive analysis, InvestingPro offers 7 additional tips for Accolade, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.